Reply to "The problem of the most appropriate curative treatment for hepatocellular carcinoma. When to embolize? When to operate?"

Affiliations

¹ Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. Electronic address: ksukorea@yuhs.ac.

Comment

Beom Kyung Kim et al. J Hepatol. 2015 Jul.

. 2015 Jul;63(1):281-2.

doi: 10.1016/j.jhep.2015.04.007. Epub 2015 Apr 14.

¹ Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. Electronic address: ksukorea@yuhs.ac.

No abstract available

Comment on

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.
Kim BK, Kim SU, Kim KA, Chung YE, Kim MJ, Park MS, Park JY, Kim DY, Ahn SH, Kim MD, Park SI, Won JY, Lee DY, Han KH. Kim BK, et al. J Hepatol. 2015 Jun;62(6):1304-10. doi: 10.1016/j.jhep.2015.01.022. Epub 2015 Jan 29. J Hepatol. 2015. PMID: 25637785
The problem of the most appropriate curative treatment for hepatocellular carcinoma. When to embolize? When to operate?
Guerra F, Levi Sandri GB. Guerra F, et al. J Hepatol. 2015 Jul;63(1):280-1. doi: 10.1016/j.jhep.2015.02.053. Epub 2015 Apr 15. J Hepatol. 2015. PMID: 25889807 No abstract available.